San Leandro, CA, United States of America

John Tessman

This inventor holds 1 USPTO granted patent. Top assignee: Cerus Corporation. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Tessman: Innovator in Photodecontamination Technologies

Introduction

John Tessman is a notable inventor based in San Leandro, CA (US). He has made significant contributions to the field of photodecontamination, particularly in the area of platelet preparations. His innovative work has led to the development of methods that enhance the safety and efficacy of medical treatments.

Latest Patents

John Tessman holds a patent for "Proralen inactivation of microorganisms and psoralen removal." This patent discloses methods for photodecontamination to inactivate microorganisms in platelet preparations. Additionally, it details the removal of psoralen after photodecontamination by contacting the psoralen with a psoralen-binding polymer. This invention is crucial for improving the safety of blood products.

Career Highlights

Throughout his career, John Tessman has been associated with Cerus Corporation, a company dedicated to developing innovative technologies for blood safety. His work at Cerus has positioned him as a key player in advancing medical technologies that protect patients from infections.

Collaborations

John Tessman has collaborated with notable colleagues, including Lily Lin and Laurence Corash. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

John Tessman's contributions to the field of photodecontamination and his patent for psoralen removal highlight his commitment to improving medical safety. His work continues to impact the healthcare industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…